Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.
OJAL, J; FLASCHE, S; Hammitt, LL; Akech, D; Kiti, MC; Kamau, T; ADETIFA, I; Nurhonen, M; SCOTT, JA G; Auranen, K;
2017
Vaccine, (2017).35 35 Pt 10.1016/j.vaccine.2017.07.019.
Factors associated with routine childhood vaccine uptake and reasons for non-vaccination in India: 1998-2008.
FRANCIS, MR; Nohynek, H; LARSON, H; Balraj, V; Mohan, VR; Kang, G; Nuorti, JP;
2017
Vaccine, (2017).36 44 10.1016/j.vaccine.2017.08.026.
Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination.
Masala, GL; Lipsitch, M; BOTTOMLEY, C; FLASCHE, S;
2017
Journal of the Royal Society, Interface / the Royal Society, (2017).14 136 10.1098/rsif.2017.0620.
Trachoma prevalence and age-specific prevalence of anti-Pgp3 antibodies from Lower River Region and Upper River Region, The Gambia.
Migchelsen, S; MABEY, D;
2017
, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2017). 10.17037/DATA.130.
Who is Spreading Rumours about Vaccines?.
Kostkova, P; Mano, V; LARSON, HJ; Schulz, WS;
2017
Proceedings of the 2017 International Conference on Digital Health (2017). 10.1145/3079452.3079505.
Tuberculosis in England, a high-income Western European setting with low incidence: Recent trends, Social determinants and Prevention through BCG vaccination.
NGUIPDOP-DJOMO, P;
2017
(2017). 10.17037/PUBS.04645351.
Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
ANWARI, P; Debellut, F; Pecenka, C; Parwiz, SM; CLARK, A; Groman, D; Safi, N;
2017
Vaccine, (2017).36 51 10.1016/j.vaccine.2017.10.058.
Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.
SUNDARAM, N; Chen, C; Yoong, J; Luvsan, M-E; Fox, K; Sarankhuu, A; La Vincente, S; JIT, M;
2017
Vaccine, (2017).35 7 10.1016/j.vaccine.2016.12.070.
Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
MANGTANI, P; NGUIPDOP-DJOMO, P; KEOGH, RH; Trinder, L; SMITH, PG; FINE, PE; Sterne, J; Abubakar, I; VYNNYCKY, E; Watson, J; Elliman, D; Lipman, M; RODRIGUES, LC;
2017
HEALTH TECHNOLOGY ASSESSMENT, (2017).21 39 10.3310/hta21390.
Enhancement of cytokine-driven NK cell IFN-γ production after vaccination of HCMV infected Africans.
DARBOE, A; DANSO, E; CLARKE, E; Umesi, A; Touray, E; Wegmuller, R; MOORE, SE; RILEY, EM; Goodier, MR;
2017
European journal of immunology, (2017).47 6 10.1002/eji.201746974.